Two doses of a combined measles-mumps-rubella-varicella vaccine (MMRV) were more efficacious at preventing moderate to severe varicella infection (chickenpox) than one dose of monovalent varicella vaccine and markedly more effective against varicella of any severity, according to a study today in The Lancet.
At a malaria conference in South Africa today, researchers reported more promising findings for a vaccine that is furthest along in development, and GlaxoSmithKline (GSK) officials said they now intend to submit a regulatory application for it to the European Medicines Agency (EMA) in 2014, according to a company press release.
Influenza activity is up "considerably" in South America and southern Africa, the World Health Organization (WHO) reported today, while other scattered regions are also seeing some increase.
Apr 11, 2013
Apr 1, 2013
